tiragolumab,Carboplatin,Atezolizumab,Etoposide
roche
['tiragolumab']
#asco22 study design for sky-2 mirrors imp133 design with addition of tiragolumab/placebo during induction and maintenance. important difference is that sky-2 allowed pts with untreated brain metastases. primary analysis was in those without brain mets, full analysis included all 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him